These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3083818)

  • 1. Requirement of ADP for arachidonic acid-induced platelet aggregation: studies with selective thromboxane-synthase inhibitors.
    Cerletti C; Minoldo S; Bucchi F; Del Maschio A; de Gaetano G
    Biochem Pharmacol; 1986 Apr; 35(7):1201-3. PubMed ID: 3083818
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 6():417-25. PubMed ID: 6247892
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of 2-indolecarbohydrazides on thromboxane synthetase activity and on in vitro and ex vivo blood platelet aggregation. New selective inhibitors.
    Monge A; Erro A; Parrado P; Font M; Aldana I; Rocha E; Fernandez-Alvarez E
    Arzneimittelforschung; 1986 Aug; 36(8):1184-6. PubMed ID: 3096343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors.
    Rajtar G; Cerletti C; Castagnoli MN; Bertelé V; de Gaetano G
    Biochem Pharmacol; 1985 Feb; 34(3):307-10. PubMed ID: 3918536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of imidazole and 9,11-azoprosta-5,13-dienoic acid. Two selective thromboxane synthetase inhibitors.
    Fitzpatrick FA; Gorman RR
    Biochim Biophys Acta; 1978 Mar; 539(2):162-72. PubMed ID: 629996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arachidonic acid induced platelet aggregation and thromboxane formation is inhibited by OKY-1581.
    Uotila P; Matintalo M; Dahl ML
    Prostaglandins Leukot Med; 1983 Nov; 12(3):299-303. PubMed ID: 6419237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathoracic platelet accumulation in the guinea-pig induced by intravenous administration of arachidonic acid--effect of cyclooxygenase and thromboxane synthetase inhibitors.
    Barrett PA; Butler KD; Shand RA; Wallis RB
    Thromb Haemost; 1986 Dec; 56(3):311-7. PubMed ID: 3105107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate.
    Carter AJ; Heptinstall S
    Thromb Haemost; 1985 Oct; 54(3):612-6. PubMed ID: 3937261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effects of acetaminophen and its analogues on human platelet aggregation and thromboxane B2 synthesis.
    Shorr RI; Kao KJ; Pizzo SV; Rauckman EJ; Rosen GM
    Thromb Res; 1985 Apr; 38(1):33-43. PubMed ID: 3923647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UK-37, 248, a novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity.
    Randall MJ; Parry MJ; Hawkeswood E; Cross PE; Dickinson RP
    Thromb Res; 1981 Jul 1-15; 23(1-2):145-62. PubMed ID: 6795753
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro antiaggregant activity of paracetamol and derivatives.
    Dupin JP; Gravier D; Casadebaig F; Boisseau MR; Bernard H
    Thromb Res; 1988 May; 50(3):437-47. PubMed ID: 3134743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders.
    Gresele P; Blockmans D; Deckmyn H; Vermylen J
    J Pharmacol Exp Ther; 1988 Jul; 246(1):301-7. PubMed ID: 3134542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of thromboxane B2 in incubates of dog platelet-rich plasma with arachidonic acid and its inhibition by different drugs.
    Chignard M; Vargaftig BB; Sors H; Dray F
    Biochem Biophys Res Commun; 1978 Dec; 85(4):1631-9. PubMed ID: 743319
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of platelet thromboxane synthesis by 7-(1-imidazolyl) heptanoic acid: dissociation from inhibition of aggregation.
    Grimm LJ; Knapp DR; Senator D; Halushka PV
    Thromb Res; 1981 Nov; 24(4):307-17. PubMed ID: 6801806
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of platelet aggregation and thromboxane production by pinacidil.
    Goodman RP; Little DM; Wright JT
    Prostaglandins Leukot Med; 1985 Aug; 19(2):115-22. PubMed ID: 3931098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs.
    Maguire MH; Csonka-Khalifah L
    Biochim Biophys Acta; 1987 Oct; 921(3):426-36. PubMed ID: 3117116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acetylsalicylic acid on platelet aggregation and thromboxane B2 production in flowing aortic blood in the rat studied with a filter loop technique.
    Martin JF; Suggett AJ; Jones PB; Leach E
    Thromb Res; 1982 Aug; 27(3):251-9. PubMed ID: 6814004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboxane synthase inhibition potentiates washed platelet activation by endogenous and exogenous arachidonic acid.
    Patscheke H
    Biochem Pharmacol; 1985 Apr; 34(8):1151-6. PubMed ID: 3922373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a selective inhibitor of thromboxane synthetase on human blood platelet behaviour.
    Heptinstall S; Bevan J; Cockbill SR; Hanley SP; Parry MJ
    Thromb Res; 1980 Oct; 20(2):219-30. PubMed ID: 7193919
    [No Abstract]   [Full Text] [Related]  

  • 20. Stored human platelets retain full aggregation potential in response to pairs of aggregating agents.
    DiMinno G; Silver MJ; Murphy S
    Blood; 1982 Mar; 59(3):563-8. PubMed ID: 6800418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.